Intelligent Bio Solutions Statistics
Share Statistics
Intelligent Bio Solutions has 6.81M
shares outstanding. The number of shares has increased by 117.63%
in one year.
| Shares Outstanding | 6.81M |
| Shares Change (YoY) | 117.63% |
| Shares Change (QoQ) | 54.63% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 470 |
| FTD / Avg. Volume | 0.28% |
Short Selling Information
The latest short interest is 541.82K, so 7.99% of the outstanding
shares have been sold short.
| Short Interest | 541.82K |
| Short % of Shares Out | 7.99% |
| Short % of Float | 8.01% |
| Short Ratio (days to cover) | 6.99 |
Valuation Ratios
The PE ratio is -0.57 and the forward
PE ratio is 3.26.
Intelligent Bio Solutions's PEG ratio is
0.01.
| PE Ratio | -0.57 |
| Forward PE | 3.26 |
| PS Ratio | 1.87 |
| Forward PS | 0.6 |
| PB Ratio | 0.7 |
| P/FCF Ratio | -0.6 |
| PEG Ratio | 0.01 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Intelligent Bio Solutions.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.57,
with a Debt / Equity ratio of 0.1.
| Current Ratio | 1.57 |
| Quick Ratio | 1.42 |
| Debt / Equity | 0.1 |
| Debt / EBITDA | -0.1 |
| Debt / FCF | -0.09 |
| Interest Coverage | -61.52 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $62,235.62 |
| Profits Per Employee | $-203,135.18 |
| Employee Count | 50 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 2.17 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -51.82% in the
last 52 weeks. The beta is 4.63, so Intelligent Bio Solutions's
price volatility has been higher than the market average.
| Beta | 4.63 |
| 52-Week Price Change | -51.82% |
| 50-Day Moving Average | 1.63 |
| 200-Day Moving Average | 1.59 |
| Relative Strength Index (RSI) | 38.61 |
| Average Volume (20 Days) | 169,096 |
Income Statement
In the last 12 months, Intelligent Bio Solutions had revenue of 3.11M
and earned -10.16M
in profits. Earnings per share was -6.38.
| Revenue | 3.11M |
| Gross Profit | 1.43M |
| Operating Income | -10.28M |
| Net Income | -10.16M |
| EBITDA | -8.81M |
| EBIT | -10.02M |
| Earnings Per Share (EPS) | -6.38 |
Full Income StatementBalance Sheet
The company has 6.3M in cash and 871.44K in
debt, giving a net cash position of 5.43M.
| Cash & Cash Equivalents | 6.3M |
| Total Debt | 871.44K |
| Net Cash | 5.43M |
| Retained Earnings | -51.96M |
| Total Assets | 8.68M |
| Working Capital | -341.24K |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -9.57M
and capital expenditures -221.43K, giving a free cash flow of -9.79M.
| Operating Cash Flow | -9.57M |
| Capital Expenditures | -221.43K |
| Free Cash Flow | -9.79M |
| FCF Per Share | -3.07 |
Full Cash Flow StatementMargins
Gross margin is 45.81%, with operating and profit margins of -330.46% and -326.4%.
| Gross Margin | 45.81% |
| Operating Margin | -330.46% |
| Pretax Margin | -327.5% |
| Profit Margin | -326.4% |
| EBITDA Margin | -283.14% |
| EBIT Margin | -330.46% |
| FCF Margin | -314.71% |
